vs

Side-by-side financial comparison of Citi Trends Inc (CTRN) and Vertex, Inc. (VERX). Click either name above to swap in a different company.

Citi Trends Inc is the larger business by last-quarter revenue ($197.1M vs $196.6M, roughly 1.0× Vertex, Inc.). Vertex, Inc. runs the higher net margin — -1.3% vs -3.5%, a 2.2% gap on every dollar of revenue. On growth, Vertex, Inc. posted the faster year-over-year revenue change (11.1% vs 10.1%). Vertex, Inc. produced more free cash flow last quarter ($7.7M vs $767.0K). Over the past eight quarters, Vertex, Inc.'s revenue compounded faster (10.5% CAGR vs -4.3%).

Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

CTRN vs VERX — Head-to-Head

Bigger by revenue
CTRN
CTRN
1.0× larger
CTRN
$197.1M
$196.6M
VERX
Growing faster (revenue YoY)
VERX
VERX
+1.0% gap
VERX
11.1%
10.1%
CTRN
Higher net margin
VERX
VERX
2.2% more per $
VERX
-1.3%
-3.5%
CTRN
More free cash flow
VERX
VERX
$6.9M more FCF
VERX
$7.7M
$767.0K
CTRN
Faster 2-yr revenue CAGR
VERX
VERX
Annualised
VERX
10.5%
-4.3%
CTRN

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CTRN
CTRN
VERX
VERX
Revenue
$197.1M
$196.6M
Net Profit
$-6.9M
$-2.5M
Gross Margin
63.5%
Operating Margin
-3.7%
31.1%
Net Margin
-3.5%
-1.3%
Revenue YoY
10.1%
11.1%
Net Profit YoY
3.6%
-122.6%
EPS (diluted)
$-0.86
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRN
CTRN
VERX
VERX
Q1 26
$196.6M
Q4 25
$197.1M
$194.7M
Q3 25
$190.8M
$192.1M
Q2 25
$201.7M
$184.6M
Q1 25
$211.2M
$177.1M
Q4 24
$179.1M
$178.5M
Q3 24
$176.6M
$170.4M
Q2 24
$186.3M
$161.1M
Net Profit
CTRN
CTRN
VERX
VERX
Q1 26
$-2.5M
Q4 25
$-6.9M
$-7.0M
Q3 25
$3.8M
$4.0M
Q2 25
$871.0K
$-961.0K
Q1 25
$-14.2M
$11.1M
Q4 24
$-7.2M
$-67.8M
Q3 24
$-18.4M
$7.2M
Q2 24
$-3.4M
$5.2M
Gross Margin
CTRN
CTRN
VERX
VERX
Q1 26
63.5%
Q4 25
64.8%
Q3 25
63.1%
Q2 25
65.7%
Q1 25
63.8%
Q4 24
65.6%
Q3 24
64.8%
Q2 24
63.7%
Operating Margin
CTRN
CTRN
VERX
VERX
Q1 26
31.1%
Q4 25
-3.7%
-1.3%
Q3 25
1.8%
2.2%
Q2 25
0.2%
-2.1%
Q1 25
0.6%
2.5%
Q4 24
-4.9%
-7.3%
Q3 24
-14.1%
2.9%
Q2 24
-3.7%
4.7%
Net Margin
CTRN
CTRN
VERX
VERX
Q1 26
-1.3%
Q4 25
-3.5%
-3.6%
Q3 25
2.0%
2.1%
Q2 25
0.4%
-0.5%
Q1 25
-6.7%
6.3%
Q4 24
-4.0%
-38.0%
Q3 24
-10.4%
4.2%
Q2 24
-1.8%
3.2%
EPS (diluted)
CTRN
CTRN
VERX
VERX
Q1 26
$-0.02
Q4 25
$-0.86
Q3 25
$0.46
Q2 25
$0.11
Q1 25
$-1.70
Q4 24
$-0.86
Q3 24
$-2.21
Q2 24
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRN
CTRN
VERX
VERX
Cash + ST InvestmentsLiquidity on hand
$252.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$107.8M
$246.5M
Total Assets
$464.3M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRN
CTRN
VERX
VERX
Q1 26
$252.5M
Q4 25
$314.0M
Q3 25
$313.5M
Q2 25
$284.4M
Q1 25
$270.4M
Q4 24
$296.1M
Q3 24
$279.0M
Q2 24
$325.5M
Total Debt
CTRN
CTRN
VERX
VERX
Q1 26
Q4 25
$337.5M
Q3 25
$336.9M
Q2 25
$336.3M
Q1 25
$335.8M
Q4 24
$335.2M
Q3 24
$334.7M
Q2 24
$334.1M
Stockholders' Equity
CTRN
CTRN
VERX
VERX
Q1 26
$246.5M
Q4 25
$107.8M
$258.9M
Q3 25
$113.2M
$264.5M
Q2 25
$108.6M
$248.0M
Q1 25
$113.2M
$200.5M
Q4 24
$130.3M
$179.4M
Q3 24
$136.6M
$259.0M
Q2 24
$154.8M
$233.1M
Total Assets
CTRN
CTRN
VERX
VERX
Q1 26
$1.2B
Q4 25
$464.3M
$1.3B
Q3 25
$457.4M
$1.2B
Q2 25
$437.4M
$1.2B
Q1 25
$462.8M
$1.2B
Q4 24
$467.1M
$1.2B
Q3 24
$506.7M
$1.2B
Q2 24
$484.1M
$1.0B
Debt / Equity
CTRN
CTRN
VERX
VERX
Q1 26
Q4 25
1.30×
Q3 25
1.27×
Q2 25
1.36×
Q1 25
1.67×
Q4 24
1.87×
Q3 24
1.29×
Q2 24
1.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRN
CTRN
VERX
VERX
Operating Cash FlowLast quarter
$8.6M
$38.0M
Free Cash FlowOCF − Capex
$767.0K
$7.7M
FCF MarginFCF / Revenue
0.4%
3.9%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRN
CTRN
VERX
VERX
Q1 26
$38.0M
Q4 25
$8.6M
$42.3M
Q3 25
$3.9M
$62.5M
Q2 25
$-11.0M
$46.0M
Q1 25
$28.5M
$14.8M
Q4 24
$-18.4M
$41.1M
Q3 24
$5.6M
$41.4M
Q2 24
$-19.6M
$57.7M
Free Cash Flow
CTRN
CTRN
VERX
VERX
Q1 26
$7.7M
Q4 25
$767.0K
Q3 25
$-1.7M
Q2 25
$-13.1M
Q1 25
$26.0M
Q4 24
$-20.4M
Q3 24
$1.7M
$-24.3M
Q2 24
$-21.2M
FCF Margin
CTRN
CTRN
VERX
VERX
Q1 26
3.9%
Q4 25
0.4%
Q3 25
-0.9%
Q2 25
-6.5%
Q1 25
12.3%
Q4 24
-11.4%
Q3 24
0.9%
-14.2%
Q2 24
-11.4%
Capex Intensity
CTRN
CTRN
VERX
VERX
Q1 26
Q4 25
4.0%
Q3 25
2.9%
Q2 25
1.0%
Q1 25
1.2%
Q4 24
1.1%
Q3 24
2.2%
38.5%
Q2 24
0.9%
Cash Conversion
CTRN
CTRN
VERX
VERX
Q1 26
Q4 25
Q3 25
1.01×
15.44×
Q2 25
-12.59×
Q1 25
1.33×
Q4 24
Q3 24
5.73×
Q2 24
11.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRN
CTRN

Segment breakdown not available.

VERX
VERX

Software subscriptions$167.1M85%
Services$29.5M15%

Related Comparisons